488 related articles for article (PubMed ID: 27156361)
1. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Kashiwagi K; Kogure S; Mabuchi F; Chiba T; Yamamoto T; Kuwayama Y; Araie M;
Acta Ophthalmol; 2016 Nov; 94(7):e561-e570. PubMed ID: 27156361
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
3. Trabeculectomy and Combined Phacoemulsification-Trabeculectomy: Outcomes and Risk Factors for Failure in Primary Angle Closure Glaucoma.
Song BJ; Ramanathan M; Morales E; Law SK; Giaconi JA; Coleman AL; Caprioli J
J Glaucoma; 2016 Sep; 25(9):763-9. PubMed ID: 27513900
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
5. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study.
Iwao K; Inatani M; Seto T; Takihara Y; Ogata-Iwao M; Okinami S; Tanihara H
J Glaucoma; 2014 Feb; 23(2):88-94. PubMed ID: 22895522
[TBL] [Abstract][Full Text] [Related]
8. Risk of sudden visual loss following filtration surgery in end-stage glaucoma.
Topouzis F; Tranos P; Koskosas A; Pappas T; Anastasopoulos E; Dimitrakos S; Wilson MR
Am J Ophthalmol; 2005 Oct; 140(4):661-6. PubMed ID: 16226517
[TBL] [Abstract][Full Text] [Related]
9. Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Leinonen S; Kotaniemi K; Kivelä T; Majander A
JAMA Ophthalmol; 2015 Nov; 133(11):1323-8. PubMed ID: 26402863
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
11. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2.
Yamamoto T; Sawada A; Mayama C; Araie M; Ohkubo S; Sugiyama K; Kuwayama Y;
Ophthalmology; 2014 May; 121(5):1001-6. PubMed ID: 24424248
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Brüggemann A; Despouy JT; Wegent A; Müller M
J Glaucoma; 2013 Sep; 22(7):577-83. PubMed ID: 23632395
[TBL] [Abstract][Full Text] [Related]
14. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Takihara Y; Inatani M; Ogata-Iwao M; Kawai M; Inoue T; Iwao K; Tanihara H
JAMA Ophthalmol; 2014 Jan; 132(1):69-76. PubMed ID: 24232829
[TBL] [Abstract][Full Text] [Related]
15. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
[TBL] [Abstract][Full Text] [Related]
16. The size of subconjunctival preparation does not influence the outcome of trabeculectomy with mitomycin C.
Wasielica-Poslednik J; Hoffmann EM; Herzog D; Aliyeva S; Lamparter J; Pfeiffer N
J Glaucoma; 2015; 24(5):e75-9. PubMed ID: 25304277
[TBL] [Abstract][Full Text] [Related]
17. Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Sugimoto Y; Mochizuki H; Ohkubo S; Higashide T; Sugiyama K; Kiuchi Y
Ophthalmology; 2015 Nov; 122(11):2223-33. PubMed ID: 26410611
[TBL] [Abstract][Full Text] [Related]
18. Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Chen PP; Moeller KL
J Glaucoma; 2019 Jan; 28(1):27-31. PubMed ID: 30394979
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma.
Yadava U; Jaisingh K; Dangda S; Thacker P; Singh K; Goel Y
Indian J Ophthalmol; 2017 Nov; 65(11):1151-1155. PubMed ID: 29133641
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Lim SH; Cha SC
J Glaucoma; 2017 Apr; 26(4):303-310. PubMed ID: 26709498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
